Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

NCT03531281 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Administratively withdrawn

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Hematopoietic Cell Transplantation Recipient

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Goat Milk
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Palifermin
DRUG: Sirolimus
DRUG: Tacrolimus
RADIATION: Total-Body Irradiation

Sponsor

City of Hope Medical Center

Collaborators

[object Object]